Trial Profile
GnRH Agonist Trigger and Modified Luteal Phase Support, Adding a Mid-luteal Bolus of GnRHa: a Randomised Controlled Trial.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Triptorelin (Primary)
- Indications Infertility
- Focus Therapeutic Use
- 05 Jul 2017 Status changed from recruiting to completed.
- 06 Feb 2017 New trial record